Hanjin KAL, HD Hyundai Marine Solution, and SK Biopharmaceuticals Excluded from MSCI Korea Index
Hanjin KAL, HD Hyundai Marine Solution, and SK Biopharmaceuticals have been excluded from the MSCI Korea Index constituents.
On May 12 (local time), global equity index provider MSCI announced the results of its May regular review, making these adjustments to the Korea Index constituents.
No new stocks have been added. Previously, Rainbow Robotics and others were mentioned as potential candidates for inclusion, but it is reported that they did not meet the requirements for market capitalization and free-float market capitalization. The index rebalancing will take place after the market closes on May 29.
MSCI reviews its indices every February, May, August, and November, adjusting constituent stocks based on total market capitalization and free-float market capitalization. In February, Hyundai Engineering & Construction and Samsung Epis Holdings were newly included, while Coway, Doosan Bobcat, and LG Household & Health Care were excluded.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If a Samsung Electronics Employee with a 100 Million Won Salary Receives a 600 Million Won Performance Bonus, Taxes Total 247.19 Million Won
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- Park Minshik Shaves Head: "I Will End Han Donghoon's Predatory and Parasitic Politics"... Ongoing Calls for Conservative Consolidation in Busan Buk-gu Gap within PPP
The MSCI Index serves as a benchmark for global investors. When a stock is included in the index, global passive funds that track this index flow in. However, when a stock is excluded, capital outflows may occur.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
